500 Days Later: Every Step Of Mylan And Upjohn’s Merger Into Viatris
$12bn Deal Aiming For $1bn Of Synergies Launched 16 November
Viatris, the combination of Mylan and Pfizer’s Upjohn unit, launched on 16 November. The culmination of almost 16 months of work, the transaction faced many hurdles, not least the devastating effects of the novel coronavirus pandemic. Generics Bulletin has collated every step of the deal in chronological order, spanning its 476-day history.
